In addition to possessing an extraordinary sweeping activity, pulmonary alveolar macrophages (PAM) are equipped with the biochemical mechanisms involved in the metabolism ofcarcinogens, which were found to be inducible in humans by cigarette smoke. Moreover, several defense processes were stimulated in rat PAM after in vivo administration of the anticarcinogen N-acetycysteine (NAC). Benzolalpyrene diol epoxide (BPDE)-DNA adducts, as revealed by synchronous fluorescence spectrophotometry, were selectively detected in PAM of smokers and persisted up to 6 months. The amount of adducts was signifcntly ated with the number of currently smoked cigarettes but not with the cigrettes smoked in a lifetime (pack-years). Nevertheless, deviations from the regression line pointed out the role ofinterindividual variability factors in adduct formation. Probably due to the low mitotic rate of PAM in the respiratory lumen, the frequency of micronuclei was not enhanced in smokers. However, parallel assays in rats shwed that micronuclei can be enhanced after massive intratracheal administmtion of benzolalpyrene or whole-body exposure to high amounts of maiunstrem cigarette smoke, which also induced BPDE-DNA adducts in lung cells and other organs, including the heart. All these adverse effects were markedly inhibited by the oral administration ofNAC, which provides the premise and rationale for a future study on the protective effects of oral NAC in heavy smokers.
Introduction
Among the cell populations that may surrogate target cells for biomonitoring purposes, pulmonary alveolar macrophages (PAM) are ofparticular interest. These long-living cells provide a formidable bulwark protecting terminal airways, which by far represent the largest surface of communication between the organism and the environment. As many as 24-120 x 106 PAM in humans (I ) and 0.75 x 106 PAM in rats (2) are removed daily from the alveolar spaces via the mucociliatory escalator. This gives an idea ofthe extraordinary sweeping activity ofthese cells, which phagocytize inhaled particulate material, often containing carcinogens resulting from tobacco smoke and/or airpollution. In addition, PAM are equipped with the inducible metabolic machinery capable ofactivating benzo[aJpyrene (BaP), which may play a role in determining DNA damage in bronchial cells (3) . However, carcinogen-detoxifying mechanisms are also present (4, 5) , which can be induced in humans by cigarette smoke (4) andin rats by anticarcinogenic thiols, such as N-acetylcysteine (NAC) (6) .
We are using human PAM, which can be collected by broncho- Half of CS-exposed animals were pretreated with NAC per os. The animals were killed 24 hr after the last treatment, and BAL was immediately performed by means of five 10-mL infusions of saline. At the same time, bone marrow smears were prepared for cytogenetic analysis, and lungs and liver were removed for evaluation of BPDE-DNA adducts.
Evaluation of BPDE-DNA Adducts DNA was extracted from PAM as previously described (9), and BPDE-DNA adducts were evaluated by means of synchronous fluorescence spectrophotometry (SFS) (10) . To obtain a standardized amount of40 itg DNA to be analyzed by SFS, in some cases, especially in nonsmokers, the DNA extracted from two to three individuals with homogeneous characteristics was pooled. In total, therefore, 27 samples were obtained as representative ofthe 39 subjects under study. Arbitrary fluorescence units (FU) were used for quantifying BPDE-DNA adducts (9).
Evaluation ofMicronucleated and Binucleated Cells
Cytocentrifuge-prepared slides were fixed and stained by means of Diff-Quik (Merz + Dade). Micronucleated (MN) and binucleated (BN) PAM were scored in blind-coded slides by two readers, each one examining 2-3000 PAM at a 1000x magnification. As shown in Figure 1 , MN can be easily distinguished from pigmented cytoplasmic granules by virtue of their structure and nucleuslike staining patterns.
Results

Micronuclei in Human PAM
The overall frequency of MN (mean + SD) in 31 subjects was 3.9 ± 1.8 %0, without any significant difference between 11 smokers (3.4 ± 2.5 %o) and 20 nonsmokers or ex-smokers (4.1 + 1.4%o). No particular trend could be related to age (18-74 years) or to sex (4.1 ± 2.1%o in 22 males, and 3.3 ± 0.7%o in 9 females), and no significant association could be established with occupation or pathological conditions.
BPDE-DNA Adducts in Human PAM
Detection of BPDE-DNA adducts in 27 samples of PAM obtained from 39 individuals was selectively related to smoking habits. In fact, no adduct was detectable by SFS in samples from 13 nonsmokers and 6 ex-smokers, who had stopped smoking at least 2 years before BAL. In contrast, the 84.7 % of samples obtanied from 16 current smokers exhibited evident SFS peaks. Also positive were the two pools of PAM obtained from four individuals (former smokers) who had stopped smoking in the last 1-6 months preceding BAL. As shown in Figure 2 , the amounts 6.4 +2. 1* 35.9 ± 11.8* Smoke (8 days) + NACperos 3.5 ± 1.6t 30.0 ± 8.6 Abbreviations: MN, micronucleated; BN, binucleated; PAM, pulmonary alveolar macrophages; BaP, benzo[a]pyrene; NAC, N-acetylcysteine. *p < 0.05 as compared to controls. **p < 0.001 as compared to controls. p < 0.05 as compared to BaP-treated rats. 'p < 0.001 as compared to BaP-treated rats.
Discussion
The results herein reported provide evidence that human PAM represent an ideal target for assessing carcinogen-DNA adducts resulting from cigarette smoke. At variance with other surrogate cells, such as peripheral blood leukocytes, in which adducts are poorly related to smoking habits (11, 12) and strongly affected by dietary carcinogens (13) , PAM analysis could selectively discriminate smokers from nonsmokers. Detection of BPDE-DNA adducts in these cells therefore provides a sensitive and specific tool in human biomonitoring. Clearly, this does not rule out the possibility that application ofeven more sensitive techniques, such as the 32P-postlabeling technique, may detect carcinogen-DNA adducts in PAM due to other sources, e.g., air pollution or passive smoke. We are currently exploring this possibility.
In spite of the significant correlation observed between the amount of BPDE-DNA adducts and the number of currently smoked cigarettes, deviations from the regression line pointed out the role of smoking style and of interindividual variability in the local metabolism of carcinogens, which was previously investigated in human PAM (4) and lung peripheral parenchyma (14, 15) . These considerations emphasize the usefulness ofassessing the internal dosimetry in exposed individuals.
Probably because of the low mitotic index of PAM in the respiratory lumen, the frequency of MN was poorly affected by the variability factors under study, including smoking habits. Therefore, this cytogenetic index is not a sensitive biomarker of human exposure to the amounts of clastogens normally inhaled with cigarette smoke. However, the parallel experiments in rats showed that a whole-body exposure to high doses of mainstream cigarette smoke, which markedly enhanced the frequency of MN in bone marrow polychromatic erythrocytes in both mice (16) and rats (this study), significantly increased MN in PAM. The intratracheal administration of high amounts of BaP, which conversely were not clastogenic in bone marrow cells, considerably enhanced MN in PAM and also produced the formation ofBPDE adducts both to lung and liver DNA (17) . As shown by preliminary results, exposure ofrats to cigarette smoke also causes the formation ofBPDE-DNA adducts detectable by SFS in the lung and other organs, including the heart (unpublished data).
It is ofinterest that cytogenetic changes and adducts produced by either BaPor cigarette smoke were efficiently prevented by the oral administration ofthethiol NAC, an anticarcinogen working through multiple mechanisms (18, 19) . We are now planning to monitor several end points, including those described in this article, to evaluate theprotective effects oforal NAC in heavy smokers.
